Management of the axilla for high-risk early breast cancer (EBC) before and after neoadjuvant chemotherapy (NACT): an analysis of the multicentre GeparOcto trial
2020
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI